Delivery Order SPE2DB22D3501-SPE2DB24FUJ82
Award Date 1/30/24
Potential Completion Date 1/31/24
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,081.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Pfizer COVID-19 vaccines, under an Emergency Use Authorization (EUA), with an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,138.52 firm fixed price delivery order is for the supply of Pfizer's COVID-19 vaccine for the 2023-2024 period, under the Emergency Use Authorization (EUA). The award is not set-aside, and is delivered under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The delivery order, valued at $1,081.34, is for the provision of Pfizer COVID-19 vaccines in 0.9mL doses over a period from 6 months to 4 years under an Emergency Use Authorization. This award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,135.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Pfizer COVID-19 vaccine doses in 0.9 mL vials. The contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is likely part of a larger indefinite delivery contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, to provide Pfizer's COVID-19 vaccine in 0.9 mL doses under an Emergency Use Authorization. The firm fixed price delivery order has a potential value of $6,258.62 and a completion date of February 7, 2024. It was awarded on February 6, 2024 and does not have a set-aside designation. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,138.52 firm fixed price delivery order is for the supply of Pfizer COVID-19 vaccines (0.9ml) to support the Department of Defense during the 2023-2024 timeframe, including an extended use authorization (EUA) period. No set-aside designations were used for this award....
- This federal contract award, valued at $1,129.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the procurement of Pfizer COVID-19 vaccines, with a period of performance from February 2025 to March 2025. The contract is a firm fixed-price arrangement and was not designated as a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,562.12 Firm Fixed Price delivery order is for the procurement of Pfizer COVID-19 vaccines (0.9 ml) to support the 2023-2024 vaccination program under the Emergency Use Authorization (EUA). The award has an ultimate completion date of February 7, 2024. AmerisourceBergen maintains a $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $1,100.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccine doses, with a period of performance from May 2024 to May 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of Pfizer's COVID-19 vaccine over a period of 6 months to 4 years, under an Emergency Use Authorization. The $2,259.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen has a significant Indefinite Delivery Contract...